Literature DB >> 28123551

Cell death in a co-culture of hepatocellular carcinoma cells and human umbilical vascular endothelial cells in a medium lacking glucose and arginine.

Minoru Tomizawa1, Fuminobu Shinozaki2, Yasufumi Motoyoshi3, Takao Sugiyama4, Shigenori Yamamoto5, Naoki Ishige6.   

Abstract

Human primary hepatocytes are able to survive in a medium without glucose and arginine that is instead supplemented with galactose and ornithine (hepatocyte selection medium; HSM). This is because the cells produce glucose and arginine by the action of galactokinase (GALK) and ornithine carbamoyltransferase (OTC), respectively. It was expected that hepatocellular carcinoma (HCC) cells do not survive in HSM. In the current study, HCC cell lines (namely HLE, HLF, PLC/PRL/5, Hep3B and HepG2) and human umbilical vascular endothelial cells (HUVECs) were cultured in HSM, and the expression levels of GALK1, GALK2 and OTC were analyzed by reverse transcription-quantitative polymerase chain reaction. HLE, HLF and PLC/PRL/5 cells died on day 11, while Hep3B, HepG2 and HUVECs died on day 7. HLF cells were further analyzed as these cells had lower expression levels of GALK1, GALK2 and OTC compared with adult liver cells, and survived until day 11. In these cells, the expression levels of GALK1, GALK2 and OTC did not change on days 3 and 7 as compared to day 0. In addition, a co-culture of HLF cells with HUVECs was established and the medium was changed to HSM. It was observed that HLF cells and HUVECs in co-culture were damaged in HSM. In summary, HCC cells and HUVECs died in a medium without glucose and arginine that was supplemented with galactose and ornithine. HCC cells and HUVECs were damaged in HSM, suggesting a potential application for treatment with the medium.

Entities:  

Keywords:  galactokinase; gluconeogenesis; ornithine carbamoyltransferase; urea cycle

Year:  2016        PMID: 28123551      PMCID: PMC5245067          DOI: 10.3892/ol.2016.5454

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  Hepatic gluconeogenic capacity from various precursors in young versus old rats.

Authors:  Ken D Sumida; Suzanne C Crandall; Puja L Chadha; Tauseef Qureshi
Journal:  Metabolism       Date:  2002-07       Impact factor: 8.694

2.  Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine.

Authors:  Minoru Tomizawa; Yoshiro Toyama; Chizuru Ito; Kiyotaka Toshimori; Katsuro Iwase; Masaki Takiguchi; Hiromitsu Saisho; Osamu Yokosuka
Journal:  Cell Tissue Res       Date:  2008-05-14       Impact factor: 5.249

Review 3.  Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future.

Authors:  Hwi Young Kim; Joong-Won Park
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

4.  Growth patterns and interstitial invasion of small hepatocellular carcinoma.

Authors:  M Tomizawa; F Kondo; Y Kondo
Journal:  Pathol Int       Date:  1995-05       Impact factor: 2.534

5.  Role of pyruvate in ischaemia-like conditions on cultured neurons.

Authors:  K Matsumoto; K Yamada; E Kohmura; A Kinoshita; T Hayakawa
Journal:  Neurol Res       Date:  1994-12       Impact factor: 2.448

Review 6.  Ammonia toxicity and its prevention in inherited defects of the urea cycle.

Authors:  V Walker
Journal:  Diabetes Obes Metab       Date:  2009-06-16       Impact factor: 6.577

7.  Fluorescence-based multiplex real-time RT-PCR arrays for the detection and serotype determination of foot-and-mouth disease virus.

Authors:  Stanley Tam; Alfonso Clavijo; Eric K Engelhard; Mark C Thurmond
Journal:  J Virol Methods       Date:  2009-05-07       Impact factor: 2.014

Review 8.  Arginine deprivation as a targeted therapy for cancer.

Authors:  L Feun; M You; C J Wu; M T Kuo; M Wangpaichitr; S Spector; N Savaraj
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Studies on primary cultures of differentiated fetal liver cells.

Authors:  H L Leffert; D Paul
Journal:  J Cell Biol       Date:  1972-03       Impact factor: 10.539

Review 10.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.

Authors:  Ran Xu Zhu; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.